Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 3, 2015, Pages E387-E395

  Grzesik, Wojciech J ^a   Nadler, Joseph L ^a   Machida, Yui ^a   Nadler, Jerry L ^a   Imai, Yumi ^a   Morris, Margaret A ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; AUTOANTIBODY; POLYPEPTIDE; VIMENTIN; PANCREAS POLYPEPTIDE;

ARTICLE; CELL COUNT; CELL LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; CELL DEDIFFERENTIATION; DONOR; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PATHOLOGY;

ARACHIDONATE 12-LIPOXYGENASE; AUTOANTIBODIES; CELL DEDIFFERENTIATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ISLETS OF LANGERHANS; PANCREAS TRANSPLANTATION; PANCREATIC POLYPEPTIDE; TISSUE DONORS; VIMENTIN;

EID: 84924973408     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3630     Document Type: Article

References (38)

1. Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res. 2011;50:115-131.
2. Kuhn H, O'Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipids Res. 2006;45:334-356.
3. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001;294:1871-1875.
4. Weaver JR, Holman TR, Imai Y, et al. Integration of pro-inflammatory cytokine, 12-lipoxygenase and NOX-1 in pancreatic islet βcell dysfunction. Mol Cell Endocrinol. 2012;358:88-95.
5. Ma K, Nunemaker CS, Wu R, Chakrabarti SK, Taylor-Fishwick DA, Nadler JL. 12-Lipoxygenase products reduce insulin secretion and β-cell viability in human islets. J. Clin. Endocrinol. Metab. 2010;95:887-893.
6. Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadler JL. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest. 1999;103:1431-1436.
7. McDuffie M, Maybee NA, Keller SR, et al. Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes. Diabetes. 2008;57:199-208.
8. Tersey SA, Maier B, Nishiki Y, Maganti AV, Nadler JL, Mirmira RG. 12-Lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets. Mol Cell Biol. 2014;34:3735-3745.
9. Butcher MJ, Hallinger D, Garcia E, et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia. 2014;57:491-501.
10. Yang Z, Chen M, Ellett JD, et al. Autoimmune diabetes is blocked in Stat4-deficient mice. J Autoimmun. 2004;22:191-200.
11. nullmice, leading to protection against type 1 diabetes development. PLoS One. 2013;8:e56763.
12. Luci DK, Jameson JB 2nd, Yasgar A, et al. Synthesis and structureactivity relationship studies of 4-((2-hydroxy-3-methoxybenzyl-)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase. J Med Chem. 2014;57:495-506.
13. Cole BK, Kuhn NS, Green-Mitchell SM, et al. 12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response. Am J Physiol Endocrinol Metab. 2012;302:E654-E665.
14. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic β cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell. 2012;150:1223-1234.
15. Lombardi A, Ulianich L, Treglia AS, et al. Increased hexosamine biosynthetic pathway flux dedifferentiates INS-1E cells and murine islets by an extracellular signal-regulated kinase (ERK)1/2-mediated signal transmission pathway. Diabetologia. 2012;55:141-153.
16. Tersey SA, Nishiki Y, Templin AT, et al. Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the non-obese diabetic mouse model. Diabetes. 2012;61:818-827.
17. Tania M, Khan MA, Fu J. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumour Biol. 2014;35:7335-7342.
18. Wang GS, Rosenberg L, Scott FW. Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats. Lab Invest. 2005;85:675-688.
19. Pugliese A, Yang M, Kusmarteva I, et al. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes. 2014;15:1-9.
20. Campbell-Thompson M, Wasserfall C, Kaddis J, et al. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev. 2012;28:608-617.
21. Wang X, Zielinski MC, Misawa R, et al. Quantitative analysis of pancreatic polypeptide cell distribution in the human pancreas. PLoS One. 2013;8:e55501.
22. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. Natural history of type 1 diabetes. Diabetes. 2005;54(suppl 2):S25-S31.
23. Wuest SJ, Crucet M, Gemperle C, Loretz C, Hersberger M. Expression and regulation of 12/15-lipoxygenases in human primary macrophages. Atherosclerosis. 2012;225:121-127.
24. Nie D, Tang K, Diglio C, Honn KV. Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. Blood. 2000;95:2304-2311.
25. Gersell DJ, Gingerich RL, Greider MH. Regional distribution and concentration of pancreatic polypeptide in the human and canine pancreas. Diabetes. 1979;28:11-15.
26. El-Gohary Y, Tulachan S, Wiersch J, et al. Asmad signaling network regulates islet cell proliferation. Diabetes. 2014;63:224-236.
27. Tokuyama Y, Sturis J, DePaoli AM, et al. Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes. 1995;44:1447-1457.
28. Shannon VR, Ramanadham S, Turk J, Holtzman MJ. Selective expression of an arachidonate 12-lipoxygenase by pancreatic islet β-cells. Am J Physiol. 1992;263:E828-E836.
29. Kawajiri H, Zhuang D, Qiao N, et al. Expression of arachidonate 12-lipoxygenase in rat tissues: a possible role in glucagon secretion. J Histochem Cytochem. 2000;48:1411-1419.
30. Hanley SC, Austin E, Assouline-Thomas B, et al. β-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology. 2010;151:1462-1472.
31. Howarth FC, Al Kitbi MK, Hameed RS, Adeghate E. Pancreatic peptides in young and elderly Zucker type 2 diabetic fatty rats. JOP. 2011;12:567-573.
32. Herrera PL, Nepote V, Delacour A. Pancreatic cell lineage analyses in mice. Endocrine. 2002;19:267-278.
33. Collombat P, Hecksher-Sorensen J, Krull J, et al. Embryonic endocrine pancreas and mature β cells acquire α and PP cell phenotypes upon Arx misexpression. J Clin Invest. 2007;117:961-970.
34. Imai Y, Dobrian AD, Morris MA, Nadler JL. Islet inflammation: a unifying target for diabetes treatment? Trends Endocrinol Metab. 2013;24:351-360.
35. Donath MY, Dalmas E, Sauter NS, Boni-Schnetzler M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 2013;17:860-872.
36. Taylor-Fishwick DA, Weaver JR, Grzesik W, et al. Production and function of IL-12 in islets and β cells. Diabetologia. 2013;56:126-135.
37. Igoillo-Esteve M, Marselli L, Cunha DA, et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia. 2010;53:1395-1405.
38. Schulthess FT, Paroni F, Sauter NS, et al. CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab. 2009;9:125-139.